Somatostatin Receptor Avidity in Gastrointestinal Stromal Tumors: Theranostic Implications of Gallium-68 Scan and Eligibility for Peptide Receptor Radionuclide Therapy.
about
Somatostatin Receptor Avidity in Gastrointestinal Stromal Tumors: Theranostic Implications of Gallium-68 Scan and Eligibility for Peptide Receptor Radionuclide Therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Somatostatin Receptor Avidity ...... Receptor Radionuclide Therapy.
@en
Somatostatin Receptor Avidity ...... Receptor Radionuclide Therapy.
@nl
type
label
Somatostatin Receptor Avidity ...... Receptor Radionuclide Therapy.
@en
Somatostatin Receptor Avidity ...... Receptor Radionuclide Therapy.
@nl
prefLabel
Somatostatin Receptor Avidity ...... Receptor Radionuclide Therapy.
@en
Somatostatin Receptor Avidity ...... Receptor Radionuclide Therapy.
@nl
P2860
P356
P1433
P1476
Somatostatin Receptor Avidity ...... Receptor Radionuclide Therapy.
@en
P2093
Arturo Loaiza-Bonilla
Paula A Bonilla-Reyes
P2860
P356
10.7759/CUREUS.1710
P577
2017-09-24T00:00:00Z